World Congress on Thyroid Cancer » The world’s most cutting-edge educational meeting for thyroid cancer professionals. A comprehensive program with the global leaders in thyroid medicine.

Kate Newbold

- Kate Newbold's presentations
  - Panel Session 5 – Radioactive Iodine Therapy and Redifferentiation Therapy for Thyroid Cancer: Who, Why, When and How?
  - IC1 – Thyroid Cancer Guidelines Around the World
Dr Kate Newbold is a Consultant in Clinical Oncology on the Head & Neck and Thyroid Unit at The Royal Marsden NHS Foundation Trust, London and Sutton, UK. She heads the Thyroid Unit and manages thyroid cancers of all stages administering radioiodine, radiotherapy and biological therapies with targeted agents. She completed basic medical training at Bristol University and practiced internal medicine in Bristol and Cheltenham before moving to London to train in clinical oncology at The Royal Marsden and Guys & St Thomas’ Hospitals.